← FDA Drug Approvals (Drugs@FDA)

ORACEA

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2006-05-26

Drug application

FDA Application #
NDA050805
Application type
New Drug Application
Brand name
ORACEA
Generic name
DOXYCYCLINE
Active ingredients
DOXYCYCLINE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
GALDERMA LABS LP
Manufacturer
Galderma Laboratories, L.P.
First approval
2006-05-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown